Research Article
Impact of Ethnicity and Underlying Comorbidity on COVID-19 Inhospital Mortality: An Observational Study in Abu Dhabi, UAE
Table 1
Comorbidities in surviving and deceased patients. Percentage indicated in relation to total group within individual comorbidity.
| | Comorbidity | Y/N (number in subcategory) | Survived (% within subcategory) | Died (%) | Univariate value |
| | Obesity | N (766) | 694 (90) | 72 (9.4) | 0.11 | | Y (216) | 187 (87) | 29 (13) | | | Unknown (93) | 93 | 0 | |
| | Diabetes | N (741) | 690 (93) | 51 (7) | <0.001 | | Y (334) | 284 (85) | 50 (15) | |
| | Hypertension | N (820) | 760 (93) | 60 (7) | <0.001 | | Y (255) | 214 (84) | 41(16) | |
| | Cardiovascular disease | N (988) | 905 (92) | 83 (8) | <0.01 | | Y (87) | 69 (79) | 18 (21) | |
| | COPD | N (1073) | 972 (91) | 101 (9) | >0.5 | | Y (2) | 2 (100) | 0 (0) | |
| | Asthma | N (1045) | 946 (91) | 99 (9) | >0.5 | | Y (30) | 28 (93) | 2 (7) | |
| | Chronic renal disease | N (1026) | 937 (91) | 89 (9) | <0.01 | | Y (49) | 37 (76) | 12 (24) | |
| | Liver disease | N (1071) | 972 (91) | 99 (9) | <0.0 | | Y (4) | 2 (50) | 2 (50) | |
| | Malignancy | N(1057) | 962 (91) | 95 (9) | <0.01 | | Y (18) | 12 (67) | 6 (33) | |
|
|
